| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Classified under Pharmaceuticals (Health Care sector), BCRX's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 1.34M | $13.00M | - | |
| CFO | 268.7K | - | - | |
| Other | 205.2K | - | - | |
| Dir | 109.6K | $1.06M | - | |
| Dir | 80.6K | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 20, 2018 | Staab Thomas R II | Senior Vice President And CFO | Sale+OE | 11,198 | $8.67 | $97,116.61 | -7.5% | |
| Nov 20, 2018 | Powell Lynne | Senior VP - CCO | Sale+OE | 15,470 | $8.55 | $132,315.44 | -86.3% | |
| Nov 8, 2018 | Staab Thomas R II | Senior Vice President And CFO | Sale+OE | 14,087 | $8.12 | $114,386.77 | -9.3% | |
| Nov 8, 2018 | Powell Lynne | Senior VP - CCO | Sale+OE | 5,580 | $8.14 | $45,432.00 | -39.3% | |
| Nov 5, 2018 | Powell Lynne | Senior VP - CCO | Sale+OE | 100 | $8.00 | $800.00 | -1.1% | |
| Nov 5, 2018 | Staab Thomas R II | Senior Vice President And CFO | Sale+OE | 215 | $8.00 | $1,720.00 | -0.2% | |
| Nov 2, 2018 | Powell Lynne | Senior VP - CCO | Sale+OE | 1,000 | $8.00 | $8,000.00 | -10.4% | |
| Nov 2, 2018 | Staab Thomas R II | Senior Vice President And CFO | Sale+OE | 10,856 | $7.84 | $85,089.68 | -7.3% | |
| Nov 1, 2018 | Powell Lynne | Senior VP - CCO | Sell | 1,544 | $7.51 | $11,595.44 | -15.2% | |
| Oct 19, 2018 | Powell Lynne | Senior VP - CCO | Sell | 100 | $7.50 | $750.00 | -1.0% |